National Center for Complementary and Alternative Medicine; Notice of Meeting, 16800 [07-1691]
Download as PDF
<![CDATA[
16800
Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 27, 2007.
Jennifer Spaeth,
Director, Officer of Federal Advisory
Committee Policy.
[FR Doc. 07–1695 Filed 4–4–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Meeting
jlentini on PROD1PC65 with NOTICES
Pursuant to Section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussion could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: June 1, 2007.
Closed: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Open: 1 p.m. to 4:30 p.m.
Agenda: Opening remarks by the Acting
Director of National Center for
Complementary and Alternative Medicine,
presentation of a new research initiative, and
other business of the Council.
VerDate Aug<31>2005
17:37 Apr 04, 2007
Jkt 211001
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room E1/E2, Bethesda, MD
20892.
Contact Person: Martin H. Goldrosen, PhD,
Executive Secretary, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 594–2014.
The public comments session is scheduled
from 4 to 4:30 p.m., but could change
depending on the actual time spent on each
agenda item. Each speaker will be permitted
5 minutes for their presentation. Interested
individuals and representatives of
organizations are requested to notify Dr.
Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland 20892, 301–594–2014,
Fax: 301–480–9970. Letters of intent to
present comments, along with a brief
description of the organization represented,
should be received no later than 5 p.m. on
May 30, 2007. Only one representative of an
organization may present oral comments.
Any person attending the meeting who does
not request an opportunity to speak in
advance of the meeting may be considered
for oral presentation, if time permits, and at
the discretion of the Chairperson. In
addition, written comments may be
submitted to Dr. Martin H. Goldrosen at the
address listed above up to ten calendar days
(June 11, 2007) following the meeting.
Copies of the meeting agenda and the
roster of members will be furnished upon
request by contacting Dr. Martin H.
Goldrosen, Executive Secretary, NACCAM,
National Center for Complementary and
Alternative Medicine, National Institutes of
Health, 6707 Democracy Boulevard, Suite
401, Bethesda, Maryland 20892, 301–594–
2014, Fax 301–480–9970, or via e-mail at
naccames@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by nongovernment
employees. Persons without a government
I.D. will need to show a photo I.D. and sign
in at the secretary desk upon entering the
building.
Dated: March 28, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1691 Filed 4–4–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Childhood Asthma Managed Program—
Cooperative Agreements.
Date: May 3, 2007.
Time: 12 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Blaine B. Moore, PhD,
Health Scientist Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7202, Bethesda, MD 20892, 301–435–0050,
mooreb@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1681 Filed 4–4–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
Public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 72, Number 65 (Thursday, April 5, 2007)]
[Notices]
[Page 16800]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1691]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine;
Notice of Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the National
Advisory Council for Complementary and Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and/or contract
proposals and the discussion could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: June 1, 2007.
Closed: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Open: 1 p.m. to 4:30 p.m.
Agenda: Opening remarks by the Acting Director of National
Center for Complementary and Alternative Medicine, presentation of a
new research initiative, and other business of the Council.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Room E1/E2, Bethesda, MD 20892.
Contact Person: Martin H. Goldrosen, PhD, Executive Secretary,
National Center for Complementary and Alternative Medicine, National
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 594-2014.
The public comments session is scheduled from 4 to 4:30 p.m.,
but could change depending on the actual time spent on each agenda
item. Each speaker will be permitted 5 minutes for their
presentation. Interested individuals and representatives of
organizations are requested to notify Dr. Martin H. Goldrosen,
National Center for Complementary and Alternative Medicine, NIH,
6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301-
594-2014, Fax: 301-480-9970. Letters of intent to present comments,
along with a brief description of the organization represented,
should be received no later than 5 p.m. on May 30, 2007. Only one
representative of an organization may present oral comments. Any
person attending the meeting who does not request an opportunity to
speak in advance of the meeting may be considered for oral
presentation, if time permits, and at the discretion of the
Chairperson. In addition, written comments may be submitted to Dr.
Martin H. Goldrosen at the address listed above up to ten calendar
days (June 11, 2007) following the meeting.
Copies of the meeting agenda and the roster of members will be
furnished upon request by contacting Dr. Martin H. Goldrosen,
Executive Secretary, NACCAM, National Center for Complementary and
Alternative Medicine, National Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax
301-480-9970, or via e-mail at naccames@mail.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by nongovernment
employees. Persons without a government I.D. will need to show a
photo I.D. and sign in at the secretary desk upon entering the
building.
Dated: March 28, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1691 Filed 4-4-07; 8:45 am]
BILLING CODE 4140-01-M
